SEC Form 4 · accession 0001162956-18-000002
Aspira Women's Health Inc. · AWHL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James T Lafrance
Director
Period of report
Aug 14, 2018
Accepted (ET)
Aug 21, 2018 · 8:57 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000926617
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Aug 14, 2018 | S | 2,573 | $0.51 | D | 318,845 | D | |
| Common StockF1,F3 | Aug 15, 2018 | S | 10,427 | $0.49 | D | 301,418 | D | |
| Common StockF1,F4 | Aug 17, 2018 | S | 7,500 | $0.51 | D | 300,918 | D | |
| Common StockF1,F5 | Aug 20, 2018 | S | 2,900 | $0.54 | D | 298,018 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- F2The sale reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.5150 to $0.5156 per share. The reporting person undertakes to provide to Vermillion, any security holder of Vermillion or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.
- F3The sale reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.4710 to $0.5150 per share. The reporting person undertakes to provide to Vermillion, any security holder of Vermillion or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.
- F4The sale reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.5059 to $0.5150 per share. The reporting person undertakes to provide to Vermillion, any security holder of Vermillion or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.
- F5The sale reported in column 4 is a weighted average price. The shares were sold in multiple transactions at $0.5375 per share. The reporting person undertakes to provide to Vermillion, any security holder of Vermillion or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.